NHS National Framework for Tafamidis

NHS England, specifically the Medicines Procurement and Supply Chain - NHS Medicines Value & Access, is establishing a national framework agreement for the supply of Tafamidis. This tender operates under reference number CM/TNS/26/5750. The initial framework period runs for 14 months, from 01 April 2027 to 31 May 2028, with a possible extension of up to 24 months at the authority's discretion. The document does not specify an estimated total value or a submission deadline. Details regarding the exact procurement procedure and eligibility criteria for bidders are not provided in the available information. Suppliers should consult the official tender documents for complete technical requirements.

Description

17 open tenders right now

• Co-producing & evaluating interventions to support MMRV uptake Somali community 11 Sep 2026 · 10 days left
• Professional and Generic Skills Programme 15 Sep 2026 · 14 days left
• Re-Published Medication to Manage Problematic Sexual Arousal (MMPSA) Service for the South-West, North-West and North-East regions (initial pilot service) 16 Sep 2026 · 15 days left

Recent awards

• NHS Work and Health Network

  awarded to The NHS Confederation

• NHS National Generic Pharmaceuticals - Wave 16a

  awarded to AFT Pharma UK Limited; AGB Pharma (UK) Ltd; AOP Orphan Limited; ASCEND LABORATORIES (UK) LIMITED; ASCOT LABORATORIES LIMITED; ASPEN PHARMACARE UK LIMITED; ASPIRE PHARMA LIMITED; Accord UK Ltd; Aguettant Limited; Amarox Limited; Arcadia Pharma Limited; B. BRAUN MEDICAL LIMITED

• Clinical database National Intestinal Failure Registry

  awarded to The British Association for Parenteral and Enteral Nutrition (BAPEN)

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

1. 31 Jul 2026 Read before bidding
   • Estimated value: Raised to €76,286,913 (+0%)
2. 31 Jul 2026 Read before bidding
   • Estimated value: Raised to €76,160,532 (+441%)
   • Submission deadline: Deadline set: August 31, 2026, 12:00
   • Scope and criteria: The description was shortened. Re-read it before you bid.
   • Estimated value: Raised to €65,281,000 (+444%)

Follow this tender and we email you the moment it changes. Create account

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€8,803,405

9,310 open across Europe right now 767% above sector average

Buyer track record on Aperlena

148 notices tracked · 100 awarded

€123,362,005 in awarded contracts